ÂÜÀòÂÒÂ×

Lamine Mbow is an experienced senior executive in the biopharmaceutical industry, currently serving as Senior Vice President and Global Head of Cancer Immunology & Immune Modulation at Boehringer Ingelheim. Prior roles include Chief Scientific Officer at both Arena Pharmaceuticals, Inc. and Ichnos Sciences, where Lamine also held the position of Senior Vice President & Head of Biologics Discovery. Lamine's earlier career includes significant roles at Boehringer Ingelheim Pharmaceuticals as Executive Director for Immunology & Inflammation and at Novartis Vaccines and Diagnostics as Unit Head for Innate Immunity and Head of the Small Molecule Immune Potentiator Platform. Lamine earned a PhD in Immunology from Université de Neuchâtel between 1990 and 1994.